IOC appoints Timothy Chang as CEO
Integrated Oncology Centres (IOC), the regional oncology arm of Singapore-based TE Asia Healthcare Partners, has appointed Timothy Chang as CEO replacing Phoebe Ho who has resigned and will be returning to Canada at the end of this year.
Mr Chang’s appointment, effective 1 October 2021, will see him lead a network of 10 cancer hospitals and centres in six markets across Asia. It comes at a time of expansion as IOC opens new facilities in Singapore and Malaysia.
Mr Chang will continue to be a Director of TE Asia, where he is a member of the investment committee and will continue deal sourcing in Southeast Asia. TE Asia, which is backed by private equity firm TPG Capital, owns specialty hospitals and medical centres across Asia, focusing on oncology, cardiology and orthopaedics.
Eng Aik Meng, Group CEO of TE Asia and Chairman of IOC, said: “We thank Phoebe for her leadership in managing and building IOC in the last six years. IOC has scaled tremendously since its first centre in Hong Kong and is now a rapidly growing network that has secured the partnerships of reputable oncologists, surgeons, radiologists, and other allied professionals across the region.
“Her prior experience as the first CEO of Hong Kong Integrated Oncology Centre (HKIOC), our first start up investment in IOC, meant that she was quick to understand the different operating support required by each of our new investments, in the different operating environments. She led the regional team in IOC, working with the resident doctors, to support the local management teams in our first few oncology investments in the region. She has been pivotal in advancing our business model of being operating partners to the clinical practices within the IOC regional network and this has been key to the provision of integrated care.”
“Timothy is no stranger to the group, being part of the pioneer team that started TE Asia Healthcare with me, he was instrumental in securing the investments within the IOC portfolio. We know he will be able to successfully build on the strong foundation laid down by Phoebe,” Mr Eng added.
As CEO, Mr Chang is expected to continue to work with the TE Asia investment team as new investments are added to the regional IOC network, with its unique Clinical Practice Partnerships with medical specialists. Doctors are empowered with equity stakes in the hospitals or centres and are key decision-makers in clinical and operational matters. This is to ensure patients receive multidisciplinary and integrated care from diagnosis to treatment and rehabilitation.
Mr Chang has over 15 years’ experience in healthcare operations and acquisitions, and held senior executive positions in hospitals across Asia, including the CEO position in Cardiac Vascular Sentral Kuala Lumpur (Malaysia), Hung Viet Cancer Hospital (Vietnam), Mahkota Medical Centre, (Malaysia) and Regency Specialist Hospital (Malaysia).